Calcineurin_NN
acts_VBZ
in_IN
synergy_NN
with_IN
PMA_NN
to_TO
inactivate_VB
I_NN
kappa_NN
B\/MAD3_NN
,_,
an_DT
inhibitor_NN
of_IN
NF-kappa_NN
B_NN
._.

The_DT
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
promoter_NN
consists_VBZ
of_IN
several_JJ
independent_JJ
T_NN
cell_NN
receptor_NN
-LRB-_-LRB-
TcR_NN
-RRB-_-RRB-
responsive_JJ
elements_NNS
._.

The_DT
induction_NN
of_IN
promoters_NNS
dependent_JJ
on_IN
these_DT
elements_NNS
is_VBZ
inhibitable_JJ
by_IN
the_DT
immunosuppressants_NNS
cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
and_CC
tacrolimus_NN
-LRB-_-LRB-
FK-506_NN
-RRB-_-RRB-
._.

Calcineurin_NN
,_,
a_DT
Ca2_NN
+_CC
\/_JJ
calmodulin-dependent_JJ
protein_NN
phosphatase_NN
,_,
is_VBZ
the_DT
FK-506_NN
-_:
and_CC
CsA-sensitive_JJ
enzyme_NN
required_VBN
for_IN
TcR_NN
mediated_VBD
activation_NN
of_IN
the_DT
IL-2_NN
promoter_NN
._.

We_PRP
report_VBP
that_IN
a_DT
constitutively_RB
active_JJ
form_NN
of_IN
calcineurin_NN
partially_RB
substitutes_VBZ
for_IN
the_DT
Ca2_NN
+_CC
co-stimulus_NN
required_VBN
to_TO
activate_VB
the_DT
IL-2_NN
promoter_NN
elements_NNS
IL-2A_NN
-LRB-_-LRB-
which_WDT
binds_VBZ
the_DT
factors_NNS
OAP_NN
and_CC
Oct-1_NN
-RRB-_-RRB-
and_CC
IL-2E_NN
-LRB-_-LRB-
which_WDT
binds_VBZ
NF-AT_NN
-RRB-_-RRB-
,_,
and_CC
completely_RB
substitutes_VBZ
for_IN
the_DT
Ca2_NN
+_CC
co-stimulus_NN
required_VBN
to_TO
stimulate_VB
an_DT
NF-kappa_NN
B-dependent_JJ
element_NN
._.

Calcineurin_NN
stimulates_VBZ
the_DT
NF-kappa_NN
B_NN
element_NN
by_IN
enhancing_VBG
inactivation_NN
of_IN
I_NN
kappa_NN
B\/MAD3_NN
,_,
an_DT
inhibitor_NN
of_IN
NF-kappa_NN
B_NN
,_,
thereby_RB
increasing_VBG
the_DT
amount_NN
of_IN
nuclear_JJ
NF-kappa_NN
B_NN
DNA_NN
binding_NN
activity_NN
._.

These_DT
data_NNS
provide_VBP
the_DT
first_JJ
demonstration_NN
in_FW
vivo_FW
that_IN
activation_NN
of_IN
a_DT
protein_NN
phosphatase_NN
can_MD
inactivate_VB
I_NN
kappa_NN
B_NN
,_,
and_CC
suggest_VBP
one_CD
possible_JJ
explanation_NN
for_IN
mechanism-based_JJ
toxicities_NNS
associated_VBN
with_IN
FK-506_NN
and_CC
CsA_NN
by_IN
demonstrating_VBG
that_IN
these_DT
drugs_NNS
can_MD
inhibit_VB
the_DT
calcineurin-dependent_JJ
activation_NN
of_IN
a_DT
virtually_RB
ubiquitous_JJ
transcription_NN
factor_NN
._.

